logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-17. Route of administration of primary drug among new and all outpatient clients in 2006 [see all tables in this series...]

Part (ii) Percentage distribution of route of administration amongst new clients with cocaine (HCl and crack) as primary drug

CountryInjectSmoke/inhaleEat/drinkSniffOthersBase (known status)Status unknown
Czech Republic0.00.00.0100.00.020
Denmark1.86.35.486.60.01123
Germany10.823.52.557.16.212651628
Ireland1.67.31.689.40.02461
Greece4.030.00.066.00.0502
Spain(1)5.211.50.580.62.2129662291
France8.230.20.061.60.028115
Italy10.047.00.440.32.499250
Cyprus3.222.60.074.20.0310
Latvia0.00.00.0100.00.020
Lithuania0.0100.00.00.00.010
Hungary(2)0.05.79.484.90.0530
Malta23.112.82.661.50.0393
Netherlands0.230.00.968.60.31530119
Austria8.91.02.088.10.01016
Slovakia0.016.70.083.30.060
Finland0.00.00.0100.00.010
Sweden0.09.412.578.10.0320
United Kingdom2.642.13.049.92.56320767
Total6.129.51.161.02.3329634835

Notes:

 Only countries where there are clients reported with cocaine (HCl and crack) as primary drug are shown. 

 (1) Data refer to 2005. 

 (2) Data refer to outpatient treatment centres and low-threshold agencies. 

 (3) Data refer to collection period between 1.4.2005 and 31.3.2006. 

 See also 'General notes for interpreting data' on the Explanatory notes and help page

Sources:

 Reitox national reports 2007 — TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Thursday, 17 July 2008